Premium
Efficacy of Imiquimod 3.75% for the treatment of extensive Bowen's disease of the face in an elderly patient
Author(s) -
Robustelli Test Elisa,
Fumo Giuseppe,
Corbeddu Marialuisa,
Ferreli Caterina,
Rongioletti Franco
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13263
Subject(s) - medicine , imiquimod , bowen's disease , dermatology , basal cell , disease , cheek , carcinoma in situ , carcinoma , surgery
Bowen's disease is a cutaneous squamous cell carcinoma (SCC) in situ with a potential risk of progression to invasive SCC. Despite the high number of approved treatments, elderly patients with extensive lesions of critical sites may represent a therapeutical challenge, especially in cases of treatment failure or recalcitrant disease. Here, we report the successfully use of topical Imiquimod 3.75% to treat an extensive Bowen's disease of the cheek in an elderly.